ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 312 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q4 2021. The put-call ratio across all filers is 0.54 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $200 | -41.7% | 7,817 | -20.0% | 0.01% | -28.6% |
| Q2 2023 | $343 | +32.9% | 9,777 | -3.7% | 0.01% | +16.7% |
| Q1 2023 | $258 | -39.4% | 10,152 | -3.3% | 0.01% | -45.5% |
| Q4 2022 | $426 | -99.9% | 10,501 | -2.8% | 0.01% | +10.0% |
| Q3 2022 | $357,000 | -7.5% | 10,808 | -1.4% | 0.01% | 0.0% |
| Q2 2022 | $386,000 | -26.3% | 10,962 | -3.8% | 0.01% | -16.7% |
| Q1 2022 | $524,000 | -28.6% | 11,392 | +2.9% | 0.01% | -25.0% |
| Q4 2021 | $734,000 | +13.3% | 11,072 | +6.7% | 0.02% | +6.7% |
| Q3 2021 | $648,000 | -25.9% | 10,372 | -1.8% | 0.02% | -28.6% |
| Q2 2021 | $875,000 | +22.0% | 10,560 | -2.3% | 0.02% | +16.7% |
| Q1 2021 | $717,000 | -14.5% | 10,810 | -1.1% | 0.02% | -14.3% |
| Q4 2020 | $839,000 | +54.5% | 10,930 | -13.3% | 0.02% | +40.0% |
| Q3 2020 | $543,000 | 0.0% | 12,610 | +0.3% | 0.02% | -6.2% |
| Q2 2020 | $543,000 | +56.0% | 12,570 | +3.8% | 0.02% | +33.3% |
| Q1 2020 | $348,000 | -55.0% | 12,110 | -0.7% | 0.01% | -42.9% |
| Q4 2019 | $774,000 | +87.9% | 12,200 | -16.6% | 0.02% | +75.0% |
| Q3 2019 | $412,000 | +6.5% | 14,630 | +0.2% | 0.01% | +9.1% |
| Q2 2019 | $387,000 | – | 14,600 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| WESTERN FINANCIAL Corp | 820,346 | $62,945,000 | 41.38% |
| Johnson & Johnson Innovation - JJDC, Inc. | 3,260,869 | $250,206,000 | 32.27% |
| Aquilo Capital Management, LLC | 365,926 | $28,078,000 | 5.84% |
| L1 Capital Pty Ltd | 298,687 | $23,127,000 | 4.32% |
| First Light Asset Management, LLC | 704,449 | $54,052,000 | 4.00% |
| ACUTA CAPITAL PARTNERS, LLC | 139,000 | $10,665,000 | 2.90% |
| Evolutionary Tree Capital Management, LLC | 48,265 | $3,703,000 | 2.82% |
| Parkman Healthcare Partners LLC | 127,171 | $9,758,000 | 2.50% |
| Capital Impact Advisors, LLC | 88,183 | $6,766,000 | 1.66% |
| Tri Locum Partners LP | 56,003 | $4,297,000 | 1.56% |